Active Ingredient: DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Proprietary Name: RENOCAL-76
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 66%;10%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A089347
Product Number: 001
Approval Date: Jun 1, 1988
Applicant Holder Full Name: BRACCO DIAGNOSTICS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
